Gel from Scientific Research

Western blot analysis of primary BMDMs treated as indicated. Where indicated, cells were pretreated with VH298 (VHLi, 1 M) or bortezomib (100 nM) for 1 h before R1-ICR-5 exposure. RIPK1 degradation was quantified by densitometry (right).

DOI